You are here:

MS in the media - 10 February 2017

Published on

4 - 10 February 2017

These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.

Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.

To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts

Obesity and early puberty as MS risk factors

Obesity in early adolescence and an earlier age at puberty are associated with a higher risk of MS in children according to a US study. The study confirms earlier research

Source: MS News Today

MS Trust link: Childhood MS

Cladribine and atrophy

Results of an analysis of the data from a previous study of cladribine, a potential disease modifying treatment for relapsing MS, suggests that over two years it is more effective that placebo at reducing the rate of brain tissue loss (atrophy) and disease progression

Source: Merck press release

MS Trust link: Cladribine

Blood test for MS type

Australian researchers have developed a blood test that will indicated which type of MS someone has with 85-90% accuracy and possibly the effectiveness of disease modifying drugs. They hope to develop a blood test kit that could be available "within as little as two years"

Source: ABC
Source: New Atlas

MS Trust link: Types of MS

Print this page